There are currently 15 active clinical trials seeking participants for Plaque Psoriasis research studies. The states with the highest number of trials for Plaque Psoriasis participants are California, Ontario, Texas and Florida.
Topical SGX302 for Mild-to-Moderate Psoriasis
NCT05442190
Recruiting
To evaluate SGX302 (topical hypericin ointment and gel) with visible light in an initial 18-week treatment course for improving lesions in patients with mild-to-moderate psoriasis.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
06/04/2025
Locations: Therapeutics Clinical Research, San Diego, California
Conditions: Psoriasis, Plaque Psoriasis, Psoriasis Vulgaris
Register for Updates
Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects
NCT05172726
Recruiting
This is an open-label, multi-center, Phase 3 study to evaluate tapinarof cream, 1% in pediatric subjects with plaque psoriasis.
Gender:
ALL
Ages:
Between 2 years and 17 years
Trial Updated:
05/30/2025
Locations: Clinical Site, Rogers, Arkansas +18 locations
Conditions: Plaque Psoriasis
Register for Updates
Guselkumab Immunogenetics
NCT04645355
Recruiting
This is a two-arm open-label study to evaluate the clinical and immunogenetic responses of patients with plaque or guttate psoriasis to treatment with guselkumab.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/06/2024
Locations: UCSF Psoriasis and Skin Treatment Center, San Francisco, California
Conditions: Psoriasis Guttate, Plaque Psoriasis
Register for Updates